The goal of this project is two-fold: 1) to increase our understanding of the neuronal circuitry critical to stress activation, stress termination, and the differential stress responsiveness across the circadian rhythm of the rat; and 2) to understand how this circuitry may be differentially activated as a function of the nature of the stressor (i.e., the ability of the animal to cope with it) and as a function of individual differences. Thus, we plan to examine, as a prototypical activational pathway, the catecholaminergic inputs which impinge upon the final common path of stress integration in the brain--the hypothalamic neurons which express corticotropin releasing hormone (CRH). We plan to ask whether the CRH neurons have compartments which can be distinguished based on gene expression, and whether these compartments are differentially responsive to differentially responsive to different stressors. In terms of stress inhibition, we shall focus on the role of the inhibitory neurotransmitter, gamma-amino-butyric acid (GABA) as a mediator of both glucocorticoid-dependent and independent negative feedback. Finally, in the anatomical studies, we shall study the role of the suprachiasmatic nucleus (SCN) as a structure which may adjust the """"""""gain"""""""" on the stress response as a function of the circadian rhythm, regulating not only the basal tone, but also stress responsiveness and stress termination. At the more behavioral level, we shall use a number of well-established models to look at how brain circuits, or specific modules within them, may become differentially activated as a function of the degree of control that the animal has over the stressor (executive vs. yoked model), or the outcome of a social stress (victory vs. defeat following an agonistic encounter). Finally, we shall ask whether animals which exhibit individual differences in stress responsiveness either at the endocrine level (Fisher vs. Lewis rats) or at the behavioral level (High responders vs. Low responders) do so because they are activating different modules of these stress-responsive neuronal circuits. Together, this set of studies should increase our understanding of the neuronal underpinning of stress responsiveness and coping with stress.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Program Projects (P01)
Project #
5P01MH042251-14
Application #
6302589
Study Section
Project Start
1999-12-01
Project End
2000-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
14
Fiscal Year
2000
Total Cost
$205,801
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Crane, Natania A; Jenkins, Lisanne M; Bhaumik, Runa et al. (2017) Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI. Brain 140:472-486
Hillhouse, Todd M; Porter, Joseph H (2015) A brief history of the development of antidepressant drugs: from monoamines to glutamate. Exp Clin Psychopharmacol 23:1-21
Meyers, K K; Crane, N A; O'Day, R et al. (2015) Smoking history, and not depression, is related to deficits in detection of happy and sad faces. Addict Behav 41:210-7
Lohoff, F W; Hodge, R; Narasimhan, S et al. (2014) Functional genetic variants in the vesicular monoamine transporter 1 modulate emotion processing. Mol Psychiatry 19:129-39
Tomita, Hiroaki; Ziegler, Mary E; Kim, Helen B et al. (2013) G protein-linked signaling pathways in bipolar and major depressive disorders. Front Genet 4:297
Votruba, Kristen L; Langenecker, Scott A (2013) Factor structure, construct validity, and age- and education-based normative data for the Parametric Go/No-Go Test. J Clin Exp Neuropsychol 35:132-46
Turner, Cortney A; Watson, Stanley J; Akil, Huda (2012) The fibroblast growth factor family: neuromodulation of affective behavior. Neuron 76:160-74
Vederman, Aaron C; Weisenbach, Sara L; Rapport, Lisa J et al. (2012) Modality-specific alterations in the perception of emotional stimuli in Bipolar Disorder compared to Healthy Controls and Major Depressive Disorder. Cortex 48:1027-34
Turner, Cortney A; Clinton, Sarah M; Thompson, Robert C et al. (2011) Fibroblast growth factor-2 (FGF2) augmentation early in life alters hippocampal development and rescues the anxiety phenotype in vulnerable animals. Proc Natl Acad Sci U S A 108:8021-5
Mickey, Brian J; Zhou, Zhifeng; Heitzeg, Mary M et al. (2011) Emotion processing, major depression, and functional genetic variation of neuropeptide Y. Arch Gen Psychiatry 68:158-66

Showing the most recent 10 out of 75 publications